Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-036717

Chief Legal Officer acquired 63,851 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mazzariello Gina Chief Legal Officer 2025-03-06 Grant or award +63,851 197,161 D
Derivatives
Mazzariello Gina Chief Legal Officer 2025-03-06 Grant or award · Stock Option (right to buy) +95,777 95,777 D
Loading xslF345X05/ownership.xml…